EXAS - EXACT Sciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EXAS is currently covered by 17 analysts with an average price target of $64.57. This is a potential upside of $16.21 (33.52%) from yesterday's end of day stock price of $48.36.

EXACT Sciences's activity chart (see below) currently has 374 price targets and 294 ratings on display. The stock rating distribution of EXAS is 93.22% BUY and 6.78% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.53% with an average time for these price targets to be met of 142.23 days.

Highest price target for EXAS is $75, Lowest price target is $65, average price target is $71.17.

Most recent stock forecast was given by VIJAY KUMAR from EVERCORE on 08-Jul-2025. First documented stock forecast 12-Oct-2012.

Currently out of the existing stock ratings of EXAS, 55 are a BUY (93.22%), 4 are a HOLD (6.78%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$68

$17.54 (34.76%)

$66

13 days ago
(08-Jul-2025)

3/9 (33.33%)

$14.46 (27.01%)

80

Buy

$65

$14.54 (28.81%)

$75

27 days ago
(24-Jun-2025)

1/5 (20%)

$13.83 (27.03%)

35

Buy

$72

$21.54 (42.69%)

$75

2 months 19 days ago
(02-May-2025)

9/10 (90%)

$20.45 (39.67%)

77

Buy

$70

$19.54 (38.72%)

$75

4 months 25 days ago
(26-Feb-2025)

4/10 (40%)

$19.82 (39.50%)

31

Buy

$65

$14.54 (28.81%)

$65

6 months 8 days ago
(13-Jan-2025)

10/13 (76.92%)

$6.49 (11.09%)

151

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EXAS (EXACT Sciences) average time for price targets to be met?

On average it took 142.23 days on average for the stock forecasts to be realized with a an average price target met ratio 70.53

Which analyst has the current highest performing score on EXAS (EXACT Sciences) with a proven track record?

KEVIN DEGEETER

Which analyst has the most public recommendations on EXAS (EXACT Sciences)?

Kevin Degeeter works at LADENBURG and has 4 price targets and 3 ratings on EXAS

Which analyst is the currently most bullish on EXAS (EXACT Sciences)?

Sandy Draper with highest potential upside - $125.35

Which analyst is the currently most reserved on EXAS (EXACT Sciences)?

Zarak Khurshid with lowest potential downside - -$43.46

EXACT Sciences in the News

Q1 2025 Exact Sciences Corp Earnings Call

Participants Derek Leckow; Vice President Investor Relations; Exact Sciences Corp Kevin Conroy; Chairman of the Board, President, Chief Executive Officer; Exact Sciences Corp Aaron Bloomer; Chief Financial Officer; Exact Sciences Corp Tycho Peterson; Analyst; Jefferies Catherine Schulte; Analyst; Baird Brandon Couillard; Analyst; Wells Fargo Securities LL Colleen Babington; Analyst; Wolfe Research, LLC Patrick Donnelly; Analyst;...

Exact Sciences (EXAS) Stock Trades Up, Here Is Why

What Happened? Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 15.2% in the morning session after the company reported strong first quarter 2025 results which beat analysts’ revenue and EBITDA expectations and included full-year revenue guidance that slightly exceeded Wall Street’s estimates. Sales grew 11% from the previous year, driven by a 14% rise...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?